T
Theravance Biopharma Inc
TBPH · NASDAQ · Healthcare · 880M
Price · close
$17.01
+0.35% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
8.1×
Price / net assetsP/B
2.9×
Enterprise value / EBITDAEV/EBITDA
5.6×
Free cash flow yieldFCF yield
27.9%
Return on equityROE
35.7%
Operating margin
-12.3%
Net debt / EBITDAbalance-sheet strength
-0.7×
Interest coverage
-5.4×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.